Log in to save to my catalogue

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative an...

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2505396314

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

About this item

Full title

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-02

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Abstract Variants in the leucine-rich repeat kinase 2 (LRRK2) gene are associated with increased risk for familial and sporadic Parkinson’s disease (PD). Pathogenic variants in LRRK2, including the common variant G2019S, result in increased LRRK2 kinase activity, supporting the therapeutic potential of LRRK2 kinase inhibitors for PD. To better unde...

Alternative Titles

Full title

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2505396314

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2505396314

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.02.23.432545